GlassScriptPhysician profile
Nikki Little
NPI 1457801623
$11,545.56
in general payments reported to CMS, 2019-2025
14 companies · $183 in 2025
The $183 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $970 · 2022: $5,087 · 2023: $1,778 · 2024: $3,527 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,734 · Food and Beverage: $1,554 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,733.89 |
| Food and Beverage | $1,554.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $6,921.90 | 2021-2023 | Pylarify |
| Telix Pharmaceuticals | $3,152.04 | 2024 | Illuccix |
| Foundation Medicine, INC. | $267.25 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.81 | 2024 | |
| Janssen Biotech, INC. | $161.81 | 2025 | Rybrevant, Carvykti, Erleada |
| Blue Earth Diagnostics | $124.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $123.99 | 2023 | Andexxa |
| Aveo Pharmaceuticals, INC. | $123.98 | 2023 | Fotivda |
| Amgen INC. | $121.87 | 2021 | |
| Janssen Scientific Affairs, LLC | $121.11 | 2024-2025 | Erleada, Pipeline |
| Boston Scientific Corporation | $120.76 | 2022 | |
| Abiomed | $38.09 | 2024 | Impella |
| Pharmacyclics LLC, An Abbvie Company | $16.00 | 2021 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Little listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.